Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)

China flag China · Delayed Price · Currency is CNY
23.16
-0.19 (-0.81%)
Last updated: Oct 10, 2025, 11:27 AM CST
-0.81%
Market Cap2.49B
Revenue (ttm)197.68M
Net Income (ttm)44.96M
Shares Out108.22M
EPS (ttm)0.41
PE Ratio55.93
Forward PEn/a
Dividend0.32 (1.37%)
Ex-Dividend DateSep 26, 2025
Volume450,386
Average Volume1,129,491
Open23.25
Previous Close23.35
Day's Range23.02 - 23.50
52-Week Range14.46 - 28.93
Beta0.46
RSI43.25
Earnings DateOct 24, 2025

About SHA:688163

Shanghai Serum Bio-Technology Co., Ltd. engages in the research, development, production, operation, and sale of antitoxin and antiserum products in China. It offers equine anti-tetanus immunoglobulin, anti-venin, and anti-rabies serum products. The company was founded in 1999 and is based in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 326
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688163
Full Company Profile

Financial Performance

In 2024, SHA:688163's revenue was 194.92 million, an increase of 2.51% compared to the previous year's 190.14 million. Earnings were 44.29 million, an increase of 14.23%.

Financial Statements

News

There is no news available yet.